ici 204,219 has been researched along with Ovarian Neoplasms in 1 studies
zafirlukast: a leukotriene D4 receptor antagonist
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gelzinis, JA | 1 |
| Szahaj, MK | 1 |
| Bekendam, RH | 1 |
| Wurl, SE | 1 |
| Pantos, MM | 1 |
| Verbetsky, CA | 1 |
| Dufresne, A | 1 |
| Shea, M | 1 |
| Howard, KC | 1 |
| Tsodikov, OV | 1 |
| Garneau-Tsodikova, S | 1 |
| Zwicker, JI | 1 |
| Kennedy, DR | 1 |
1 other study available for ici 204,219 and Ovarian Neoplasms
| Article | Year |
|---|---|
Targeting thiol isomerase activity with zafirlukast to treat ovarian cancer from the bench to clinic.
Topics: Animals; Blood Platelets; Female; Humans; Indoles; Mice; Ovarian Neoplasms; Phenylcarbamates; Sulfhy | 2023 |